P31749 |
AKT1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P31749 |
AKT1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P31749 |
AKT1_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P31749 |
AKT1_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P31749 |
AKT1_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P31749 |
AKT1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P31749 |
AKT1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P31749 |
AKT1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P31749 |
AKT1_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P31749 |
AKT1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P31749 |
AKT1_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P31749 |
AKT1_HUMAN |
Injury [ICD-11: NA00-ND5Z] |
P31749 |
AKT1_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P31749 |
AKT1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P31749 |
AKT1_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P31749 |
AKT1_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P31749 |
AKT1_HUMAN |
Overgrowth syndrome [ICD-11: LD2C] |
P31749 |
AKT1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P31749 |
AKT1_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P31749 |
AKT1_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P31749 |
AKT1_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P52333 |
JAK3_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P52333 |
JAK3_HUMAN |
Psoriasis [ICD-11: EA90] |
P52333 |
JAK3_HUMAN |
Alopecia [ICD-11: ED70] |
P52333 |
JAK3_HUMAN |
Asthma [ICD-11: CA23] |
P52333 |
JAK3_HUMAN |
Crohn disease [ICD-11: DD70] |
P52333 |
JAK3_HUMAN |
Acquired hypomelanotic disorder [ICD-11: ED63] |
P52333 |
JAK3_HUMAN |
Atopic eczema [ICD-11: EA80] |
P52333 |
JAK3_HUMAN |
B-cell lymphoma [ICD-11: 2A86] |
P52333 |
JAK3_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P52333 |
JAK3_HUMAN |
Pruritus [ICD-11: EC90] |
P52333 |
JAK3_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P52333 |
JAK3_HUMAN |
Transplant rejection [ICD-11: NE84] |
P52333 |
JAK3_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P52333 |
JAK3_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P52333 |
JAK3_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
O15530 |
PDPK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
O15530 |
PDPK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11309 |
PIM1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11309 |
PIM1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11309 |
PIM1_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P12931 |
SRC_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P12931 |
SRC_HUMAN |
Ischemia [ICD-11: 8B10-8B11] |
P12931 |
SRC_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P12931 |
SRC_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P12931 |
SRC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P12931 |
SRC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P12931 |
SRC_HUMAN |
BCR-ABL1-negative chronic myeloid leukaemia [ICD-11: 2A41] |
P12931 |
SRC_HUMAN |
Brain cancer [ICD-11: 2A00] |
P12931 |
SRC_HUMAN |
Cervical cancer [ICD-11: 2C77] |
P12931 |
SRC_HUMAN |
Endometrial cancer [ICD-11: 2C76] |
P12931 |
SRC_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
P12931 |
SRC_HUMAN |
Fallopian tube cancer [ICD-11: 2C74] |
P12931 |
SRC_HUMAN |
Gastrointestinal stromal tumour [ICD-11: 2B5B] |
P12931 |
SRC_HUMAN |
Leiomyosarcoma [ICD-11: 2B58] |
P12931 |
SRC_HUMAN |
Malignant digestive organ neoplasm [ICD-11: 2C11] |
P12931 |
SRC_HUMAN |
Metastatic digestive system neoplasm [ICD-11: 2D8Y] |
P12931 |
SRC_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
P12931 |
SRC_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P12931 |
SRC_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P12931 |
SRC_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P12931 |
SRC_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
P12931 |
SRC_HUMAN |
Sarcoma [ICD-11: 2A60-2C35] |
P12931 |
SRC_HUMAN |
Synovial sarcoma [ICD-11: 2B5A] |
P12931 |
SRC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P12931 |
SRC_HUMAN |
Osteosarcoma [ICD-11: 2B51] |
P12931 |
SRC_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P12931 |
SRC_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P12931 |
SRC_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P12931 |
SRC_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P12931 |
SRC_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P12931 |
SRC_HUMAN |
Gram-positive bacterial infection [ICD-11: 1B74-1F40] |
P12931 |
SRC_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P15056 |
BRAF_HUMAN |
Melanoma [ICD-11: 2C30] |
P15056 |
BRAF_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P15056 |
BRAF_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P15056 |
BRAF_HUMAN |
Melanoma [ICD-11: 2C30] |
P15056 |
BRAF_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P24864 |
CCNE1_HUMAN |
Retina cancer [ICD-11: 2D02] |
P28702 |
RXRB_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P48443 |
RXRG_HUMAN |
Kinetoplastids [ICD-11: 1F61-1G2Z] |
P48443 |
RXRG_HUMAN |
Light sensitivity impairment [ICD-11: 9D45] |
P48443 |
RXRG_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P48443 |
RXRG_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P48443 |
RXRG_HUMAN |
Lung cancer [ICD-11: 2C25] |
P48443 |
RXRG_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P48443 |
RXRG_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P48443 |
RXRG_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P49841 |
GSK3B_HUMAN |
Myotonic disorder [ICD-11: 8C71] |
P49841 |
GSK3B_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P49841 |
GSK3B_HUMAN |
Fragile X chromosome [ICD-11: LD55] |
P49841 |
GSK3B_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P49841 |
GSK3B_HUMAN |
Osteosarcoma [ICD-11: 2B51] |
P49841 |
GSK3B_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P49841 |
GSK3B_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P49841 |
GSK3B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P49841 |
GSK3B_HUMAN |
Brain cancer [ICD-11: 2A00] |
P49841 |
GSK3B_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P49841 |
GSK3B_HUMAN |
Transplant rejection [ICD-11: NE84] |
P49841 |
GSK3B_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P49841 |
GSK3B_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
Q05397 |
FAK1_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
Q05397 |
FAK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
Q05397 |
FAK1_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
Q05397 |
FAK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q05397 |
FAK1_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
Q05397 |
FAK1_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q9UM73 |
ALK_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
Q9UM73 |
ALK_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q9UM73 |
ALK_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
Q9UM73 |
ALK_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q9UM73 |
ALK_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q9UM73 |
ALK_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
Q9UM73 |
ALK_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q9UM73 |
ALK_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
Q9UM73 |
ALK_HUMAN |
Metastatic tumour [ICD-11: 2D50-2E2Z] |
Q9UM73 |
ALK_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |